Filter your results
- 4
- 4
- 4
- 1
- 1
- 2
- 4
- 4
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 3
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
How to diagnose parkinsonian central pain?Parkinsonism & Related Disorders, 2019, 64 (10), pp.50-53. ⟨10.1016/j.parkreldis.2019.04.025⟩
Journal articles
hal-02384349v1
|
||
|
Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous).Ann Phys Rehabil Med, 2009, 52 (2), pp.124-41. ⟨10.1016/j.rehab.2008.12.011⟩
Journal articles
inserm-00435410v1
|
||
|
Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion?Pain, 2008, 138 (2), pp.343-53. ⟨10.1016/j.pain.2008.01.006⟩
Journal articles
inserm-00292335v1
|
||
|
Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.Annals of Neurology, 2008, 64 (3), pp.274-83. ⟨10.1002/ana.21427⟩
Journal articles
inserm-00292356v1
|